Stanford Health Policy is a joint effort of the Freeman Spogli Institute for International Studies and the Stanford School of Medicine
Publications
Publications
Featured Publications
TIME Magazine
David Studdert
The Lancet
Michelle Mello
Publications
Filter:
Filter results Close
The Americas
Caribbean
Antigua & Barbuda
Bahamas
Barbados
Cuba
Dominica
Dominican Republic
Grenada
Haiti
Jamaica
St. Kitts & Nevis
St. Lucia
St. Vincent & the Grenadines
Trinidad & Tobago
Central America
Belize
Costa Rica
El Salvador
Guatemala
Honduras
Nicaragua
Panama
North America
Canada
Mexico
United States
South America
Argentina
Bolivia
Brazil
Chile
Colombia
Ecuador
Guyana
Paraguay
Peru
Suriname
Uruguay
Venezuela
Asia-Pacific
Northeast Asia
China
Japan
Mongolia
North Korea
South Korea
Taiwan
Oceania
Australia
Fiji
Kiribati
Marshall Islands
Micronesia
Nauru
New Zealand
Palau
Papua New Guinea
Samoa
Solomon Islands
Tonga
Tuvalu
Vanuatu
South Asia
Afghanistan
Bangladesh
Bhutan
India
Maldives
Nepal
Pakistan
Sri Lanka
Southeast Asia
Brunei
Burma
Cambodia
East Timor
Indonesia
Laos
Malaysia
Philippines
Singapore
Thailand
Vietnam
Europe
Eastern Europe
Albania
Bosnia & Herzegovina
Bulgaria
Croatia
Kosovo
Macedonia
Montenegro
Romania
Serbia
Central Europe
Austria
Czech Republic
Germany
Hungary
Liechtenstein
Poland
Slovakia
Slovenia
Switzerland
Iberian Peninsula
Andorra
Portugal
Spain
Scandinavia and Baltic Rim
Denmark
Estonia
Finland
Latvia
Lithuania
Norway
Sweden
Western Europe
Belgium
Cyprus
France
Greece
Iceland
Ireland
Italy
Luxembourg
Malta
Monaco
Netherlands
San Marino
United Kingdom
Vatican City
Middle East and North Africa
Algeria
Bahrain
Egypt
Iran
Iraq
Israel
Jordan
Kuwait
Lebanon
Libya
Morocco
Oman
Qatar
Saudi Arabia
Syria
Tunisia
Turkey
United Arab Emirates
Yemen
Russia and Eurasia
Armenia
Azerbaijan
Belarus
Georgia
Kazakhstan
Kyrgyzstan
Moldova
Russia
Tajikistan
Turkmenistan
Ukraine
Uzbekistan
Sub-Saharan Africa
Angola
Benin
Botswana
Burkina Faso
Burundi
Cameroon
Cape Verde
Central African Republic
Chad
Comoros
D.R. Congo
Congo
Côte d'Ivoire
Djibouti
Equatorial Guinea
Eritrea
Ethiopia
Gabon
Gambia
Ghana
Guinea
Guinea-Bissau
Kenya
Lesotho
Liberia
Madagascar
Malawi
Mali
Mauritania
Mauritius
Mozambique
Namibia
Niger
Nigeria
Rwanda
Säo Tomé & Príncipe
Senegal
Seychelles
Sierra Leone
Somalia
South Africa
South Sudan
Sudan
Swaziland
Tanzania
Togo
Uganda
Zambia
Zimbabwe
Governance
Corruption
Democracy
Democracy promotion
Disaster response
Staff
Elections
European Union
Health care institutions
Health Care Reform
Homeland Security
Human Rights
Information Technology
Intelligence
Institutions and Organizations
International Law
Kyoto Protocol
Media
Military
NATO
Negotiation
Peacekeeping
Nuclear policy
Policy Analysis
Rule of Law
State-building
World Bank
World Trade Organization
International Relations
Agricultural trade
Borders
Business
Diplomacy
Foreign Aid
Foreign Policy
Globalization
HIV/AIDS
Investment
Migration and Citizenship
Protectionism
Trade
Health and Medicine
Children's health
Early Childhood Development
Health
Vision Care
Comparative effectiveness research
Diabetes
Health policy
Hypertension
Hunger
Disease
Global Health
Health and the Environment
Health Care
Health Outcomes
Nutrition
Obesity
Population health
Public Health
Smoking
International Development
In the Classroom
Technology
Agriculture policy
Cleantech
Economic Affairs
Education
Entrepreneurship
Food Markets
Food Security
Innovation
Poverty
Science and Technology
Security
Arms Control
Arms Smuggling
Biosecurity
Bioterrorism
Civil Wars
Conflict
Crime
Cybersecurity
Drug trafficking
Kidnapping
Missiles
Nuclear Risk
Nuclear Safety
Terrorism
Torture convention
Violence
Energy
Biofuels
Cap and Trade
Coal
Electricity
Energy and Climate Policy
Energy Infrastructure
Energy Services
Fossil Fuels
Natural gas
Nuclear Energy
Natural gas
Renewable Resources
Oil
Water
Environment
Palm Oil
Agriculture
Aquaculture
Climate
Climate change
Deforestation
Fisheries
Natural Resources
Sustainable development
Society
Aging
Inclusion and Exclusion
Inequality
Migration
Migration and Citizenship
Race
SAI
Culture
Demographics
Discrimination
Ethnicity
Gender
History
Islam
Religion
Abstracts
Blogs
Books
Book Chapters
Case Studies
Conference Memos
Commentary
Dissertations
Journal Articles
News
Policy Briefs
Q&As
Testimonies
White Papers
Reports
Working Papers
Annual Reports
Brochures
Newsletters
Mark A. Hlatky
Journal Articles
Association of Adverse Pregnancy Outcomes With Risk of Atherosclerotic Cardiovascular Disease in Postmenopausal Women
Mark A. Hlatky, Marcia Stefanick
JAMA Cardiology,
2020
September 16, 2020
Cardiovascular disease is the leading cause of death among women in the U.S. and identification of sex-specific risk factors could enhance cardiovascular risk assessment and prevention. Pregnancy is an exposure unique to women: 85% of women give birth at least once in their lives, and up to 30% may experience an adverse pregnancy outcome (APO).
Journal Articles
PCSK9 Inhibitors Economics and Policy
Mark A. Hlatky, Dhruv S. Kazi
Journal of the American College of Cardiology,
2017
November 1, 2017
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors substantially reduce low-density lipoprotein cholesterol, but it is presently unclear whether they also reduce mortality. The list prices of PCSK9 inhibitors in the United States (>$14,500 per year) are >100× higher than generic statins, and only a small fraction of their higher cost is likely to be recovered by prevention of cardiovascular events.
Journal Articles
Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL
James V. Freeman, David W. Hutton, Geoffrey D. Barnes, Ruo P. Zhu, Douglas K. Owens, Alan M. Garber, Alan S. Go, Mark A. Hlatky, Paul A. Heidenreich, Paul J. Wang, Amin Al-Ahmad, Mintu P. Turakhia
Circulation: Arrhythmia and Electrophysiology,
2016
June 15, 2016
Background—Randomized trials of left atrial appendage (LAA) closure with the Watchman device have shown varying results, and its cost effectiveness compared with anticoagulation has not been evaluated using all available contemporary trial data.
Journal Articles
Quality of Life and Economic Outcomes of Assessing Fractional Flow Reserve With Computed Tomography Angiography
Mark A. Hltaky, Bernard De Bruyne, Gianluca Pontone, Manesh R. Patel, Bjarne L. Norgaard, Robert A. Byrne, Nick Curzen, Ian Purcell, Matthias Gutberlet, Gilles Rioufol, Ulrich Hink, Herwig Walter Schuchlenz, Gudrun Feuchtner, Martine Gilard, Daniele Andreini, Jesper M. Jensen, Martin Hadamitzky, Alan Wilk, Furong Wang, Campbell Rogers, Pamela S. Douglas
Journal of the American College of Cardiology,
2015
October 13, 2015
Evaluating patients who may have coronary artery disease (CAD) is a challenging and extensive process. With an array of testing options and possible results, finding a method that is accurate, cost-effective, and as uninvasive as possible helps patients achieve a higher quality of life during the testing process.
Journal Articles
Cost-Effectiveness of Adding Cardiac Resynchronization Therapy to an Implantable Cardioverter-Defibrillator Among Patients With Mild Heart Failure
Christopher Y. Woo, Erika J. Strandberg, Michelle D. Schmiegelow, Allison L. Pitt, Mark A. Hlatky, Douglas K. Owens, Jeremy D. Goldhaber-Fiebert
2015
August 25, 2015
A new study by Stanford researchers indicates adding cardiac resynchronization therapy to an implanted cardioverter-defibr
Journal Articles
Risk of Cardiovascular Events Associated With Current Exposure to HIV Antiretroviral Therapies in a US Veteran Population
Manisha Desai, Vilija Joyce, Eran Bendavid, Richard A. Olshen, Mark A. Hlatky, Adam Chow, Mark Holodniy, Paul Barnett, Douglas K. Owens
Clinical Infectious Diseases,
2015
August 1, 2015
Background. To characterize the association of antiretroviral drug combinations on risk of cardiovascular events.
Journal Articles
Association of coronary CT angiography or stress testing with subsequent utilization and spending among medicare beneficiaries
Shreibati, J.B., Laurence Baker, Mark Hlatky
JAMA - Journal of the American Medical Association,
2011
December 31, 2011
Journal Articles
Cost Effectiveness of Genetic Eesting in Family Members of Patients with Long QT Syndrome
Marco V. Perez, Narmadan A. Kumarasamy, Douglas K. Owens, Paul J Wang, Mark Hlatky
Circulation: Cardiovascular Quality and Outcomes,
2010
December 7, 2010
Background— Family members of patients with established long-QT syndrome (LQTS) often lack definitive clinical findings, yet may have inherited an LQTS mutation and be at risk of sudden death. Genetic testing can identify mutations in 75% of patients with LQTS, but genetic testing of family members remains controversial.
Journal Articles
Cost-Effectiveness of Using High-Sensitivity C-Reactive Protein to Identify Intermediate- and Low-Cardiovascular-Risk Individuals for Statin Therapy
Lee KK, Cipriano LE, Douglas K. Owens, Go AS, Mark Hlatky
Circulation,
2010
September 1, 2010
BACKGROUND: -Many myocardial infarctions and strokes occur in individuals with low-density lipoprotein cholesterol levels below recommended treatment thresholds. High sensitivity C-reactive protein (hs-CRP) testing has been advocated to identify low- and intermediate-risk individuals who may benefit from statin therapy. Methods and Results-A decision analytic Markov model was used to follow hypothetical cohorts of individuals with normal lipid levels but without coronary artery disease, peripheral arterial disease, or diabetes mellitus.
Journal Articles
Repeat Coronary Revascularization Procedures after Successful Bare-Metal or Drug-Eluting Stent Implantations
Cynthia A. Yock, Isbill JM, King SB, Mark Hlatky
Journal of Invasive Cardiology,
2010
January 1, 2010
Journal Articles
CABG versus PCI for multivessel coronary artery disease - authors' reply
Mark A. Hlatky, Dena M. Bravata, Kathryn M. McDonald, Douglas Owens
The Lancet,
2009
December 31, 2009
Working Papers
A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease
(The BARI 2D Study Group), Robert L. Frye, Phyllis August, Maria Mori Brooks, Regina M. Hardison, Sheryl F. Kelsey, Joan M. MacGregor, Trevor J. Orchard, Bernard R. Chaitman, Saul M. Genuth, Suzanne H. Goldberg, Mark A. Hlatky, Teresa L.Z. Jones, Mark E. Molitch, Richard W. Nesto, Edward Y. Sako, Burton E. Sobel
New England Journal of Medicine,
2009
June 11, 2009
Background Optimal treatment for patients with both type 2 diabetes mellitus and stable ischemic heart disease has not been established.
Journal Articles
The Year in Epidemiology, Health Services Research, and Outcomes Research
Mark A. Hlatky, Paul A. Heidenreich
Journal of the American College of Cardiology,
2009
April 21, 2009
There have been many new developments in the broad fields of epidemiology, health services research (HSR), and outcomes research during the past year, many more than can be discussed in detail in this review. We selected articles published since the last article in this series, covering roughly the period April 2007 through March 2008, that examined important issues or advanced research methods in the field.
Journal Articles
Coronary Artery Bypass Surgery Compared with Percutaneous Coronary Interventions for Multivessel Disease: A Collaborative Analysis of Individual Patient Data from Ten Randomised Trials
Mark A. Hlatky, Boothroyd DB, Dena M. Bravata, Boersma E, Booth J, Brooks MM, Carrie MD, Clayton TC, Danchin N, Flather M, Hamm CW, Hueb WA, Kahler J, Kelsey SF, King SB, Kosinski AS, Lopes N, Kathryn M. McDonald, Rodriguez A, Serruys P, Sigwart P, Stables RH, Douglas K. Owens, Pocock SJ
The Lancet,
2009
March 20, 2009
Background
Coronary artery bypass graft (CABG) and percutaneous coronary intervention (PCI) are alternative treatments for multivessel coronary disease. Although the procedures have been compared in several randomised trials, their long-term effects on mortality in key clinical subgroups are uncertain. We undertook a collaborative analysis of data from randomised trials to assess whether the effects of the procedures on mortality are modified by patient characteristics.
Journal Articles
Isolated disease of the proximal left anterior descending artery. comparing the effectiveness of percutaneous coronary interventions and coronary artery bypass surgery
John R. Kapoor, Allison L. Gienger, Reza Ardehali, Robin Varghese, Marco V. Perez, Vandana Sundaram, Kathryn M. McDonald, Douglas K. Owens, Mark A. Hlatky, Dena Bravata
JACC: Cardiovascular Interventions,
2008
December 31, 2008
Objectives: This study sought to systematically compare the effectiveness of percutaneous coronary intervention and coronary artery bypass surgery in patients with single-vessel disease of the proximal left anterior descending (LAD) coronary artery.
Background: It is uncertain whether percutaneous coronary interventions (PCI) or coronary artery bypass grafting (CABG) surgery provides better clinical outcomes among patients with single-vessel disease of the proximal LAD.
Journal Articles
Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE Study.
Assimes TL, Knowles JW, Basu A, Iribarren C, Southwick A, Tang H, Ashber D, Li J, Fair JM, Rubin GD, Sidney S Sidney S, Stephen P. Fortmann, Go AS, Mark A. Hlatky, Myers RM, Risch N, Quertermous T
Human Molecular Genetics,
2008
December 31, 2008
A susceptibility locus for coronary artery disease (CAD) at chromosome 9p21 has recently been reported, which may influence the age of onset of CAD. We sought to replicate these findings among white subjects and to examine whether these results are consistent with other racial/ethnic groups by genotyping three single nucleotide polymorphisms (SNPs) in the risk interval in the Atherosclerotic Disease, Vascular Function, and Genetic Epidemiology (ADVANCE) study. One or more of these SNPs was associated with clinical CAD in whites, U.S. Hispanics and U.S. East Asians.
Journal Articles
Incidental Pulmonary Nodules on Cardiac Computed Tomography: Prognosis and Use
Iraberren C, Mark A. Hlatky, Chandra M, Fair JM, Rubin GD, Go AS, Burt JR, Stephen P. Fortmann
American Journal of Medicine,
2008
November 1, 2008
BACKGROUND: Small asymptomatic lung nodules are found frequently in the course of cardiac computed tomography (CT) scanning. However, the utility of assessing and reporting incidental findings in healthy, asymptomatic subjects is unknown.
Journal Articles
Common Polymorphisms of ALOX5 and ALOX5AP and Risk of Coronary Artery Disease
Assimes TL, Knowles JW, Priest JR, Basu A, Volcik KA, Southwick A, Tabor HK, Hartiala J, Allayee H, Grove ML, Tabibiazar R, Sidney S, Stephen P. Fortmann, Go A, Mark A. Hlatky, Iribarren C, Boerwinkle E, Myers R, Risch N, Quertermous T
Human Genetics,
2008
March 28, 2008
Recent human genetic studies suggest that allelic variants of leukotriene pathway genes influence the risk of clinical and subclinical atherosclerosis. We sequenced the promoter, exonic, and splice site regions of ALOX5 and ALOX5AP and then genotyped 7 SNPs in ALOX5 and 6 SNPs in ALOX5AP in 1,552 cases with clinically significant coronary artery disease (CAD) and 1,583 controls from Kaiser Permanente including a subset of participants of the coronary artery risk development in young adults study. A nominally significant association
Journal Articles
Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery
Dena M. Bravata, Allison Gienger, Kathryn M. McDonald, Vandana Sundaram, MV Perez, R Varghese, JR Kapoor, R Ardehali, Douglas K. Owens, Mark A. Hlatky
Annals of Internal Medicine,
2007
November 20, 2007
Background: The comparative effectiveness of coronary artery bypass graft (CABG) surgery and percutaneous coronary intervention (PCI) for patients in whom both procedures are feasible remains poorly understood.
Purpose: To compare the effectiveness of PCI and CABG in patients for whom coronary revascularization is clinically indicated.
Journal Articles
Rosiglitazone Increased Heart failure But Did Not Differ from Metformin Plus Sulfonylurea for Other CV Outcomes at Interim Analysis
Mark A. Hlatky, Dena M. Bravata
American College of Physicians Journal Club,
2007
November 1, 2007
Journal Articles
Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Surgery
Dena M. Bravata, Allison Gienger, Kathryn M. McDonald, Vandana Sundaram, MV Perez, R Varghese, JR Kapoor, R Ardehali, Douglas K. Owens, Mark A. Hlatky
Annals of Internal Medicine,
2007
October 15, 2007
Background: The comparative effectiveness of coronary artery bypass graft (CABG) surgery and percutaneous coronary intervention (PCI) for patients in whom both procedures are feasible remains poorly understood.
Purpose: To compare the effectiveness of PCI and CABG in patients for whom coronary revascularization is clinically indicated.
Data Sources: MEDLINE, EMBASE, and Cochrane databases (1966-2006); conference proceedings; and bibliographies of retrieved articles.
Journal Articles
Statin and Beta-Blocker Therapy and the Initial Presentation of Coronary Heart Disease
A Go, C Iribarren, M Chandra, PV Lathon, Stephen P. Fortmann, T Quertermous, Mark Hlatky
Annals of Internal Medicine,
2006
February 21, 2006
Background:
Coronary atherosclerosis develops slowly over decades but is frequently characterized clinically by sudden unstable episodes. Patients who present with unstable coronary disease, such as acute myocardial infarction, may systematically differ from patients who present with relatively stable coronary disease, such as exertional angina.
Objective:
To examine whether medication use or patient characteristics influence the mode of initial clinical presentation of coronary disease.
Design:
Case-control study.
Setting:
Journal Articles
Cost-Effectiveness of Implantable Cardioverter-Defibrillators
Gillian D. Sanders, Mark A. Hlatky, Douglas K. Owens
New England Journal of Medicine,
2005
October 6, 2005
Background:
Eight randomized trials have evaluated whether the prophylactic use of an implantable cardioverter-defibrillator (ICD) improves survival among patients who are at risk for sudden death due to left ventricular systolic dysfunction but who have not had a life-threatening ventricular arrhythmia. We assessed the cost-effectiveness of the ICD in the populations represented in these primary-prevention trials.
Methods:
Journal Articles
Evidence-based medicine and policy: the case of the implantable cardioverter defibrillator
Mark A. Hlatky, Gillian D. Sanders, Douglas K. Owens
Health Affairs,
2005
January 1, 2005
The implantable cardioverter defibrillator (ICD) is a costly new treatment for patients at high risk of sudden cardiac death. Randomized trials of the ICD showed it to be effective in some groups of patients but not in others. While new trials testing the ICD were ongoing to clarify the evidence, policymakers faced immediate decisions about providing insurance coverage for the device.
Journal Articles
Health-related quality of life in patients with pulmonary arterial hypertension
Mary K. Goldstein, Shafazand S, Doyle RL, Mark A. Hlatky, Michael K. Gould
Chest,
2004
November 1, 2004
STUDY OBJECTIVES: Patients with pulmonary arterial hypertension (PAH) often present with dyspnea and severe functional limitations, but their health-related quality of life (HRQOL) has not been studied extensively. This study describes HRQOL in a cohort of patients with PAH.
DESIGN: Cross-sectional study.
SETTING: A tertiary care, university hospital-based, pulmonary hypertension (PH) clinic.